Children at high risk for schizophrenia

• TYPE OF PSYCHOLOGY: Psychopathology
• Research concerning children of parents with schizophrenia aims to identify the indicators of risk for psychiatric conditions. Longitudinal studies may provide information regarding developmental precursors of adult schizophrenia. Early intervention programs involve the administration of preventive medication to targeted at-risk individuals.

Introduction

Though the underlying mechanisms of schizophrenia are not fully understood, by the 1960s, it was well established that schizophrenia often ran in families. Between 0.30 and 0.45 percent of the global population is diagnosed with schizophrenia. In contrast, children who have one biological parent with schizophrenia have a 13 percent chance of developing the disorder. When both biological parents are diagnosed with schizophrenia, the risk rate is around 40 percent. If one's biological twin is diagnosed with schizophrenia, there is a 50 percent chance of developing the condition. While schizophrenia has a strong genetic component, genes are not the sole determinant of developing the condition.

Historically, the term “high risk” has been applied to the biological offspring of individuals with schizophrenia because of their predisposition to develop schizophrenia. Researchers have studied these individuals and their children to understand the origins of schizophrenia. Traditional studies focused on the high-risk children of parents with schizophrenia, and the second generation of high-risk studies focused on adolescents and young adults with a family history of schizophrenia and treated them in early intervention programs.

Researchers have studied schizophrenia from many perspectives with various methods attempting to understand the risk factors associated with developing schizophrenia. Some progress has been made in clarifying the nature and course of schizophrenia, and there have been considerable advances in the pharmacological treatment of symptoms. However, despite decades of research, causes, prevention methods, and cures remain unknown.

Because the onset of schizophrenia usually occurs in late adolescence or early adulthood, most patients only receive diagnoses and begin treatment after experiencing symptoms for some time. At that point, researchers must rely on the patient and other informants for information about the nature of the individual’s adjustment before the condition's onset. These retrospective accounts of the patient’s functioning are often incomplete and can be biased.

In response to this concern, several investigators emphasized the importance of studying the development of individuals known to be at heightened statistical risk for schizophrenia. Specifically, it was proposed that repeated assessments should be conducted so that data on all aspects of the development of at-risk children would be available by the time they enter the adult risk period for schizophrenia. In this way, it might be possible to identify precursors of the illness in subjects who had not yet received any treatment. Additionally, studying subjects before the provision of treatment makes it possible to differentiate the true precursors of the illness from the consequences or side effects of treatment.

Methodological Issues

One of the challenges in conducting research investigating the genetic component of schizophrenia is locating a sample. Schizophrenia is relatively rare, occurring in less than 1 percent of the general population. Moreover, because most patients experience an onset of illness in late adolescence or early adulthood, they are less likely to marry or have children. This is especially true of male patients with schizophrenia. About half of all women diagnosed with schizophrenia become mothers. To identify an adequate sample size, researchers may establish formal arrangements with local treatment facilities to increase their chances of identifying all children in their geographic area who are at an increased risk for developing schizophrenia due to genetic traits.

Another important issue is when the study should be initiated. Most investigators are interested in identifying the earliest signs of vulnerability for schizophrenia. Therefore, it is desirable to initiate a high-risk study with infant subjects. In this way, investigators can examine the entire premorbid life course of patients. If there are any markers of vulnerability apparent in infancy, they will be able to identify them. The investigator who initiates a study of infants, however, must wait an extended period to gather any information about their adult psychiatric outcomes. To reduce the time between the initiation of the study and the entry of the subjects into the major risk period for schizophrenia, most investigators have initiated high-risk projects on subjects who are in middle or late childhood.

The problem of attrition (loss of subjects) is another concern. The long-term goal is to compare those genetically predisposed children who develop schizophrenia to those who do not. Consequently, the most crucial information will be provided only when the researchers are knowledgeable about the adult psychiatric outcome of the subjects. Because a sample of one hundred high-risk children may eventually yield only ten to fifteen patients who are diagnosed with schizophrenia, it is critical for investigators to maintain contact with all subjects so they can determine their adult psychiatric outcomes.

Selecting an appropriate comparison group is salient to high-risk researchers aiming to identify specific signs of vulnerability to schizophrenia. An important question is whether the signs identified by researchers are simply manifestations of vulnerability to any adult psychiatric disorder or signs of specific vulnerability to schizophrenia. To address this question, it is necessary to include groups of children whose parents have psychiatric disorders other than schizophrenia.

Early Studies

Conducting longitudinal studies of children with a genetic predisposition to psychiatric conditions is an efficient way of studying individuals who are most likely to develop schizophrenia. The first large-scale prospective longitudinal study of high-risk children occurred in Denmark from 1962 to 1986, conducted by Sarnoff Mednick and Fini Schulsinger. They followed a group of 207 children at high risk for schizophrenia and 104 control children whose parents had no psychiatric disorder. The study found that children with a higher incidence of schizophrenia in their families, those who experienced perinatal trauma, and those who experienced unstable parenting were diagnosed with schizophrenia at a greater rate. After the Danish study was initiated, a number of other research groups started similar high-risk research programs.

A second longitudinal study of particular note is the New York High-Risk Project, led by L. Erlenmeyer-Kimling and B. Cornblatt from 1971 to 1997. The study followed two independent series of three groups of children: children with at least one parent with schizophrenia, children with one or two parents with major depressive disorder or bipolar disorder, and children whose parents were not diagnosed with or described as having a mental health condition. One notable feature of the New York High-Risk Project is that the investigators included an at-risk comparison group consisting of offspring of other individuals with severe psychiatric conditions. Comparisons between high-risk offspring (children with at least one parent with schizophrenia) and offspring of parents with mood disorders are especially useful in identifying behavioral precursors that are specifically associated with the later development of schizophrenia rather than an adult psychiatric outcome in general.

Research Findings

The results from studies of high-risk children suggest that the predisposition for schizophrenia may be detectable at an early age. Reports on the developmental characteristics of high-risk children have revealed important differences between children of parents with schizophrenia and children whose parents have no mental illness. These differences tend to fall into three general areas: motor functions, cognitive functions, and social adjustment. When compared with children of parents without reported or diagnosed mental illness, high-risk subjects have been found to show a variety of impairments in motor development and motor abilities. Infant offspring of individuals with schizophrenia tend to show delays in motor skill development, such as crawling and walking. Similarly, studies of high-risk subjects in their middle childhood and early adolescent years reveal deficits in fine and gross motor skills and coordination. It is important to emphasize, however, that these deficiencies are not of such a severe magnitude that the child would be viewed as clinically impaired in motor skills. However, the deficiencies are apparent when high-risk children, as a group, are compared with children of parents without mental health conditions.

Numerous studies have found that children at high risk for schizophrenia also show impairments in cognitive functions. Although their scores on standardized tests of intelligence are within the normal range, they tend to be slightly below those of children of parents who are not high-risk. Some research has found that high-risk children show deficiencies in their capacity to maintain and focus attention. These deficiencies are apparent as early as the preschool years and involve the processing of both auditory and visual information. Recall that the New York High-Risk Project included a comparison group of offspring of individuals with affective illnesses, such as depression. The results of the project, which started in 1971 and followed the offspring from childhood to mid-adulthood, indicated that attention deviance, gross motor skill impairments, and memory deficits were relatively unique to the risk for schizophrenia. Erlenmeyer-Kimling and associates have noted that among all the neurobehavioral predictors of the later development of schizophrenia, attention deviance was the most specifically related to genetic risk for schizophrenia. In the New York High-Risk Project, the offspring of parents with schizophrenia showed more attention deviance than either the offspring of affectively ill parents or the offspring of parents who were not considered high-risk. Because attention deficits have been found so consistently in high-risk children, some researchers have suggested they may be a key marker of risk for schizophrenia.

When compared with children of parents without psychiatric disorders, offspring of parents with schizophrenia tend to manifest a higher rate of behavioral problems. These include a higher rate of aggressive behaviors, as well as an increased frequency of social withdrawal. In general, children of parents with schizophrenia are perceived as less socially competent than comparison children. It is important to consider, however, that children of parents with other psychiatric disorders are also found to show problems with social adjustment. Consequently, it is unlikely that behavioral adjustment problems are uniquely characteristic of risk for schizophrenia.

Research Applications

The goal of high-risk research is to identify factors that can successfully predict those who are most likely to develop subsequent cases of schizophrenia or schizophrenia-related disorders. Only a subgroup—in fact, a minority—of high-risk children will eventually manifest schizophrenia. The most significant question, therefore, is not what differentiates high-risk children from a comparison group but rather what differentiates high-risk children who develop schizophrenia from high-risk children who do not. Even those individuals predicted to be at heightened risk who do not develop schizophrenia are interesting and potentially informative. The high-risk offspring who do not develop schizophrenia can inform investigators about resiliency factors that are likely to be important. Only a few high-risk research projects have followed their subjects into adulthood. Thus, only limited data regarding the childhood characteristics that predict adult psychiatric outcomes are available. The findings from these studies confirm the predictions made by the researchers. Specifically, the high-risk children who eventually develop schizophrenia show more evidence of motor abnormalities, memory deficits, and attention dysfunction in childhood than their peers.

The findings of neurobehavioral abnormalities in preschizophrenic individuals during childhood are consistent with the etiologic hypotheses held by most researchers in the field. Specifically, such abnormalities would be expected in a disorder that is presumed to be attributable to a impairment that is, at least in part, genetically determined. These findings are consistent with the hypothesis that an early brain insult may manifest itself in neurobehavioral abnormalities early on but can remain latent (unexpressed) as clinical symptoms for many years.

Limitations

Like all research approaches, the high-risk method has limitations. One limitation concerns whether these study results can be generalized to a wider population. Although schizophrenia indeed tends to run in families, it is also true that the majority of individuals with schizophrenia do not have a parent with the condition. Children of parents who have schizophrenia may represent a unique subgroup of patients with schizophrenia—because they have a parent with the condition, they may have a higher genetic loading for the disorder than patients whose parents have schizophrenia who have no mental illness.

Moreover, there are some environmental stresses associated with being reared by a parent with schizophrenia. In sum, high-risk children who develop schizophrenia who have a biological parent who also has the condition may differ from other patients in terms of genetic and environmental factors, including exposure to lead, prenatal exposure to hunger, neuromechanical irregularities, dense living conditions, and some infections. Other problems with the method mentioned above include subject attrition and the extensive waiting period required before the adult psychiatric outcome is determined.

Some investigators have attempted to address the issue of identifying markers of vulnerability with alternative methodologies. For example, one group has used childhood home movies of patients with adult-onset schizophrenia as a database for identifying infant and early childhood precursors. The findings from these studies are consistent with those from high-risk research. Others have studied siblings of individuals with schizophrenia who are within the period of greatest risk for the development of the disorder (ages eighteen through thirty). Biological siblings of individuals with schizophrenia are at heightened risk for the development of schizophrenia, typically approximately ten to fourteen times greater than the general population.

Implications of Genetic High-Risk Studies

These research findings indicate that individuals who develop schizophrenia in adulthood manifest signs of vulnerability long before the onset of the disorder, perhaps as early as infancy. These findings have some important implications. First, they provide some clues to etiology; they suggest that the neuropathological process underlying schizophrenia begins long before the onset of the clinical symptoms that define the condition. Therefore, the search for the biological bases of this illness must encompass the entire premorbid life course. Second, the findings suggest that it may be possible to identify individuals who are at risk for schizophrenia so that preventive interventions can be provided.

Early Intervention and Preventive Medication

Findings based on the first generation of high-risk studies provide the framework for establishing the of prodromal clinical indicators and for understanding the nature of the premorbid as well as the earliest prodromal (prepsychotic) phases of schizophrenia.

Since the late l990s, several clinicians and investigators in North America, Europe, and Australia have begun to identify and treat adolescents and young adults at clinical risk for schizophrenia or in the prodromal phase of the disorder. In most programs, targeted at-risk individuals are treated preemptively with low doses of atypical antipsychotic medications such as risperidone (Risperdal) and olanzapine (Zyprexa). The goal of this treatment is to prevent the onset of the illness, or at least to halt its progression. However, because no one is certain how many individuals in the clinically at-risk group would actually develop schizophrenia if left untreated, early intervention in schizophrenia is an ethically complex issue that has met with some controversy.

Patrick McGorry and Alison Yung, one of the first to initiate an early intervention program, have been outspoken proponents of the preventive medication strategy. They argue that the premorbid and prodromal phases are windows of opportunity for intervention. Indeed, some research suggests that the longer the duration of untreated psychosis, the poorer the disease outcome. However, the prodromal phase—the period directly preceding the onset of psychosis—is often only determined retrospectively. The development of schizophrenia is neither inevitable nor predetermined for any of the at-risk individuals enrolled in these early intervention programs. Therefore, there will be individuals in the treatment group who never develop the illness; these are known as false positives.

Defining At-Risk Clinical Status

To minimize the number of false positives, careful screening and identification of the at-risk population is critical. McGorry, Yung, and associates consider individuals meeting any of their definitions of at-risk mental state as being at ultra-high risk. They define at-risk mental status as attenuated (subsyndromal) psychotic symptoms; transient psychotic symptoms that resolve within one week; or genetic risk for schizophrenia that was accompanied by a marked decline in functioning over six months. Other clinical research teams, such as the one led by Barbara Cornblatt and Todd Lencz, have adopted additional criteria for defining at-risk mental status. The expanded criteria include subsyndromal negative symptoms of schizophrenia, such as social withdrawal, depressed mood, reduced motivation, sleep disturbance, and anxiety. The advantage of this approach is that it enables earlier identification of clinical high-risk individuals and, therefore, possible earlier enrollment in the preventive treatment program. The researchers note that many at-risk individuals may later show attenuated psychotic symptoms. Regardless of their definition of at-risk mental status, there is consensus among the early intervention researchers that individuals who enroll in these programs must be either symptomatic or subjectively distressed, be seeking treatment, and equally important, must give their informed consent.

Treatment Issues

Early intervention programs have been criticized because although the predictive accuracy of presumed prodromal signs and symptoms has not been established, many research clinicians are treating at-risk individuals with antipsychotic medications. Although the newer antipsychotic medications have lower risks of extrapyramidal symptoms and tardive dyskinesia, they are nonetheless associated with significant weight gain, sexual side effects, and long-term medical complications such as diabetes and cardiovascular problems. Others point out that the effects of long-term treatment with atypical antipsychotic medications on the developing adolescent brain are unknown. One distinctive aspect of Cornblatt and Lencz’s early intervention program in New York is that the first line of treatment offers alternatives to antipsychotic medications. According to preliminary reports, treatment with antidepressants, antianxiety medications, and mood stabilizers has been equally effective as antipsychotics in terms of improving the functioning of the clinically at-risk participants.

Outcomes

The interim findings of early intervention studies have become available. Overall, the studies are consistent in terms of the percentage of at-risk individuals who developed a psychotic disorder within approximately two years. The results of a multisite longitudinal study of at-risk individuals in North America revealed that 35 percent of the group developed psychosis. McGorry’s group reported that 40 percent of their at-risk participants developed psychosis. Genetic risk with functional decline was a strong predictor of later psychotic outcomes. The possibility that the percentage of at-risk individuals who developed schizophrenia or another severe mental health condition over that time period might have been considerably higher had they not been enrolled in an early intervention program cannot be ruled out.

There are potential advantages and disadvantages associated with this second generation of high-risk research. The advances in high-risk research indicate that there are several methods for viewing the developmental course of schizophrenia. These methods include not only prospectively following genetically high-risk individuals through the age of risk, but also following clinically high-risk individuals and intervening preemptively, while collecting information regarding their neurocognitive, social, psychophysiological, and clinical functioning.

Continuing Research

A 2020 meta-analysis of research concerning the genetic component of schizophrenia found that individuals with a close relative with schizophrenia are seven to eight times more likely to develop the condition, and those with more than one close relative with schizophrenia were up to eleven times more likely to develop the condition. If both parents have schizophrenia, the child’s chance of developing the condition is between 35 and 45 percent. Many studies estimate the heritability factor plays a 60 to 80 percent role in the risk of developing schizophrenia. These rates remain consistent even when the child is adopted or raised in a home away from their birth parents. These children are also at a higher risk of developing other mental health conditions, such as avoidant personality disorder.

Bibliography

Bearden, Carrie E., et al. “The Neurodevelopmental Model of Schizophrenia: Updated.” Developmental Psychopathology: Volume Three: Risk, Disorder, and Adaptation, 2nd ed., Wiley, 2015, pp. 542–69, doi:10.1002/9780470939406.ch14. Accessed 7 Jan. 2025.

Clarke, Jodi. "Causes and Risk Factors of Schizophrenia." VeryWell Mind, 25 Mar. 2024, www.verywellmind.com/what-causes-schizophrenia-2953136. Accessed 5 Jan. 2025.

Corcoran, Cheryl, et al. “Prodromal Interventions for Schizophrenia Vulnerability: The Risks of Being ’At Risk.’” Schizophrenia Research, vol. 73, no. 2, pp. 173–84, doi:10.1016/j.schres.2004.05.021. Accessed 7 Jan. 2025.

Erlenmeyer-Kimling, L., et al. “Attention, Memory, and Motor Skills as Childhood Predictors of Schizophrenia-Related Psychoses: The New York High-Risk Project.” American Journal of Psychiatry, vol. 157, no. 9, 2000, pp. 1416–22, doi:10.1176/appi.ajp.157.9.141. Accessed 7 Jan. 2025.

Goode, Erica. “Doctors Try a Bold Move against Schizophrenia.” The New York Times, 7 Dec. 1999, www.nytimes.com/1999/12/07/science/doctors-try-a-bold-move-against-schizophrenia.html. Accessed 7 Jan. 2025.

Karaca, Aysel, et al. “Being a Child of a Parent with a Diagnosis of Schizophrenia or Bipolar Disorder: A Qualitative Study.” Archives of Psychiatric Nursing, vol. 50, 2024, pp. 94–99, doi:10.1016/j.apnu.2024.03.011. Accessed 7 Jan. 2025.

Mednick, S. A., et al. “The Copenhagen High-Risk Project, 1962-86.” Schizophrenia Bulletin, vol. 13, no. 3, 1987, pp. 485–95, doi:10.1093/schbul/13.3.485. Accessed 5 Jan. 2025.

Mednick, S. A., and T. F. McNeil. “Current Methodology in Research on the Etiology of Schizophrenia: Serious Difficulties Which Suggest the Use of the High-Risk-Group Method.” Psychological Bulletin, vol. 70, no. 6, 1968, pp. 681–93, doi:10.1037/h0026836. Accessed 7 Jan. 2025.

Seeman, Mary V. “Grappling with Issues of Motherhood for Women with Schizophrenia.” Healthcare, vol. 11, no. 21, 2023, doi:10.3390/healthcare11212882. Accessed 5 Jan. 2025.

Seidman, L. J., et al. “Neuropsychological Performance and Family History in Children at Age 7 Who Develop Adult Schizophrenia or Bipolar Psychosis in the New England Family Studies.” Psychological Medicine, vol. 43, no. 1, 2013, pp. 119–31, doi:10.1017/S0033291712000773. Accessed 7 Jan. 2025.

Torrey, E. Fuller. Surviving Schizophrenia: A Family Manual. 7th ed., Harper Perennial, 2019.

Yung, Alison R., et al. Youth Mental Health: Approaches to Emerging Mental Ill-Health in Young People. Routledge, 2021.